Golin 0.25 Mg Tablet, a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of Acromegaly, Prolactinoma.
The optimal dosage of Golin 0.25 Mg Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Golin 0.25 Mg Tablet can also lead to other problems, which have been listed below. These side effects of Golin 0.25 Mg Tablet are usually temporary and subside with the completion of treatment. However, if these continue for a longer time, consult your doctor right away.
Golin 0.25 Mg Tablet's effect during pregnancy is Mild and Severe while nursing. In addition, Golin 0.25 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Golin 0.25 Mg Tablet related warnings section.
Golin 0.25 Mg Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Golin 0.25 Mg Tablet in conditions like High Blood Pressure, Heart Disease, Depression. Other conditions have been mentioned below in the Golin 0.25 Mg Tablet contraindications section.
Besides this, Golin 0.25 Mg Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Golin 0.25 Mg Tablet is considered not safe while driving, and is not addictive.
Golin 0.25 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Golin 0.25 Mg Tablet safe for pregnant women?
Golin rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Golin 0.25 Mg Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Golin. It should only be taken after medical advice.
What is the effect of Golin 0.25 Mg Tablet on the Kidneys?
There can be some harmful effects on your kidneys after taking Golin. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Golin 0.25 Mg Tablet on the Liver?
There may be an adverse effect on the liver after taking Golin. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Golin 0.25 Mg Tablet on the Heart?
The heart can be affected by Golin. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Golin 0.25 Mg Tablet unless your doctor advises you to do so -
Is this Golin 0.25 Mg Tablet habit forming or addictive?
Golin 0.25 Mg Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Golin 0.25 Mg Tablet as you may feel sleepy.
Is it safe?
Yes, but consume Golin 0.25 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, Golin 0.25 Mg Tablet cannot treat any kind of mental disorder.
Interaction between Food and Golin 0.25 Mg Tablet
Information is not available on the interaction of any foods with Golin 0.25 Mg Tablet, due to a lack of research on this.
Interaction between Alcohol and Golin 0.25 Mg Tablet
Side effects of drinking alcohol and taking Golin 0.25 Mg Tablet at the same time are rare and minor. However, if you face any side effects, talk to your doctor immediately.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-176
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 239-240
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Dostinex® (cabergoline)